The need for new paradigms

“The pandemic has changed everything about the pace of our innovation and our focus,” says Peyton Howell, EVP and Chief Commercial & Strategy Officer at Parexel. There used to be lots of caution around using real-world data and evidence, but this year has illustrated the need for new paradigms. Patient access, diversity and speed have also been central to Parexel’s innovations during the COVID era, and how the organization is building for clinical trials of the future. The industry must continue “focusing on that urgency and agility, and making sure that we don’t go back.” Watch:

Peyton Howell is Executive Vice President and Chief Commercial & Strategy Officer at Parexel

Click here to see more from ACRO in Action: Lessons learned in the COVID era

Scroll to Top